The Vaccine Reaction By TVR Staff
On June 1, 2022, Pfizer and BioNTech submitted an application to the U.S. Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) to distribute their messenger RNA (mRNA) BNT162b2 (also known as âComirnatyâ) COVID-19 biologic for children as young as six months to five years old. The application is for a three-dose regimen, with each dose containing three micrograms (”g) of the product.1 2
In a public statement, the FDA said:
We recognize parents are anxious to have their young children vaccinated against COVID-19 and while the FDA cannot predict how long its evaluation of the data and information will take, we will review any EUA request we receive as quickly as possible using a science-based approach.1
The data provided by Pfizer and BioNTech to the FDA for BNT162b2 use in children six months to five years old was taken from a Phase 2/3 trial involving 1,678 children. Preliminary results determined the reduced dose biologic to have an estimated efficacy of 80.3 percent at preventing COVID disease after three doses.1Â 2
This is pure evil. I donât think God has much mercy for those who commit crimes against children.